{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:40:22Z","timestamp":1788795622371,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11239-021-02398-3","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T16:02:40Z","timestamp":1614355360000},"page":"889-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stroke and presence of patent foramen ovale in sickle cell disease"],"prefix":"10.1007","volume":"52","author":[{"given":"Constantina","family":"Aggeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6151-5938","authenticated-orcid":false,"given":"Kali","family":"Polytarchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Dimitroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Patsourakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Delicou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Vassilopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Tsiamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"2398_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","volume":"337","author":"HF Bunn","year":"1997","unstructured":"Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762\u2013769","journal-title":"N Engl J Med"},{"key":"2398_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood.v65.1.183.bloodjournal651183","volume":"65","author":"GM Brittenham","year":"1985","unstructured":"Brittenham GM, Schechter AN, Tom Noguchi C (1985) Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 65:183\u2013189. https:\/\/doi.org\/10.1182\/blood.v65.1.183.bloodjournal651183","journal-title":"Blood"},{"key":"2398_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. The Lancet 376:2018\u20132031","journal-title":"The Lancet"},{"key":"2398_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD et al (2018) Sickle cell disease. Nat Rev Dis Primers 4:1\u201322","journal-title":"Nat Rev Dis Primers"},{"key":"2398_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s11239-013-0895-y","volume":"35","author":"RP Naik","year":"2013","unstructured":"Naik RP, Streiff MB, Lanzkron S (2013) Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis 35:352\u2013358","journal-title":"J Thromb Thrombolysis"},{"key":"2398_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/17474086.2018.1407240","volume":"11","author":"J Ansari","year":"2018","unstructured":"Ansari J, Moufarrej YE, Pawlinski R, Gavins FNE (2018) Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease. Expert Rev Hematol 11:45\u201355. https:\/\/doi.org\/10.1080\/17474086.2018.1407240","journal-title":"Expert Rev Hematol"},{"key":"2398_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ana.410230204","volume":"23","author":"SG Pavlakis","year":"1988","unstructured":"Pavlakis SG, Bello J, Prohovnik I et al (1988) Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 23:125\u2013130. https:\/\/doi.org\/10.1002\/ana.410230204","journal-title":"Ann Neurol"},{"key":"2398_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1182\/blood.V91.1.288","volume":"91","author":"K Ohene-Frempong","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288\u2013294. https:\/\/doi.org\/10.1182\/blood.V91.1.288","journal-title":"Blood"},{"key":"2398_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/jpepsy\/jsz031","volume":"44","author":"KV Prussien","year":"2019","unstructured":"Prussien KV, Jordan LC, Debaun MR, Compas BE (2019) Cognitive function in sickle cell disease across domains, cerebral infarct status, and the lifespan: a meta-analysis. J Pediatr Psychol 44:948\u2013958. https:\/\/doi.org\/10.1093\/jpepsy\/jsz031","journal-title":"J Pediatr Psychol"},{"key":"2398_CR10","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","volume":"4","author":"MR DeBaun","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 4:1554\u20131588. https:\/\/doi.org\/10.1182\/bloodadvances.2019001142","journal-title":"Blood Adv"},{"key":"2398_CR11","first-page":"CD012389","volume":"4","author":"LJ Estcourt","year":"2020","unstructured":"Estcourt LJ, Kimber C, Hopewell S et al (2020) Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Cochrane Database Syst Rev 4:CD012389","journal-title":"Cochrane Database Syst Rev"},{"key":"2398_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"P Lechat","year":"1988","unstructured":"Lechat P, Mas JL, Lascault G et al (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318:1148\u20131152. https:\/\/doi.org\/10.1056\/NEJM198805053181802","journal-title":"N Engl J Med"},{"key":"2398_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","volume":"40","author":"AA Alsheikh-Ali","year":"2009","unstructured":"Alsheikh-Ali AA, Thaler DE, Kent DM (2009) Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 40:2349\u20132355. https:\/\/doi.org\/10.1161\/STROKEAHA.109.547828","journal-title":"Stroke"},{"key":"2398_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jacc.2017.12.059","volume":"71","author":"MK Mojadidi","year":"2018","unstructured":"Mojadidi MK, Zaman MO, Elgendy IY et al (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71:1035\u20131043","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2398_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/jamaneurol.2020.0458","volume":"77","author":"AY Elgendy","year":"2020","unstructured":"Elgendy AY, Saver JL, Amin Z et al (2020) Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol 77(7):878\u2013886. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0458","journal-title":"JAMA Neurol"},{"key":"2398_CR16","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","volume":"71","author":"PH Lee","year":"2018","unstructured":"Lee PH, Song JK, Kim JS et al (2018) Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 71:2335\u20132342. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.046","journal-title":"J Am Coll Cardiol"},{"key":"2398_CR17","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00415-018-8865-0","volume":"265","author":"B Miranda","year":"2018","unstructured":"Miranda B, Fonseca AC, Ferro JM (2018) Patent foramen ovale and stroke. J Neurol 265:1943\u20131949. https:\/\/doi.org\/10.1007\/s00415-018-8865-0","journal-title":"J Neurol"},{"key":"2398_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11239-018-1633-2","volume":"46","author":"JJ Shatzel","year":"2018","unstructured":"Shatzel JJ, Daughety MM, Prasad V, DeLoughery TG (2018) PFO closure for secondary stroke prevention: is the discussion closed? J Thromb Thrombolysis 46:74\u201376","journal-title":"J Thromb Thrombolysis"},{"key":"2398_CR19","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","volume":"119","author":"MR DeBaun","year":"2012","unstructured":"DeBaun MR, Armstrong FD, McKinstry RC et al (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119:4587\u20134596","journal-title":"Blood"},{"key":"2398_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","volume":"127","author":"MR Debaun","year":"2016","unstructured":"Debaun MR, Kirkham FJ (2016) Central nervous system complications and management in sickle cell disease. Blood 127:829\u2013838","journal-title":"Blood"},{"key":"2398_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2019.02.018","volume":"95","author":"D Hirtz","year":"2019","unstructured":"Hirtz D, Kirkham FJ (2019) Sickle cell disease and stroke. Pediatr Neurol 95:34\u201341","journal-title":"Pediatr Neurol"},{"key":"2398_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Investig 127:750\u2013760","journal-title":"J Clin Investig"},{"key":"2398_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2018.12.012","volume":"189","author":"J Ansari","year":"2019","unstructured":"Ansari J, Gavins FNE (2019) Ischemia-reperfusion injury in sickle cell disease: from basics to therapeutics. Am J Pathol 189:706\u2013718","journal-title":"Am J Pathol"},{"issue":"2","key":"2398_CR24","doi-asserted-by":"publisher","first-page":"e89012","DOI":"10.1371\/journal.pone.0089012","volume":"9","author":"R Proenca\u0327-Ferreira","year":"2014","unstructured":"Proenca\u0327-Ferreira R, Brugnerotto AF, Garrido VT et al (2014) Endothelial activation by platelets from sickle cell anemia patients. PLoS ONE 9(2):e89012. https:\/\/doi.org\/10.1371\/journal.pone.0089012","journal-title":"PLoS ONE"},{"key":"2398_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199202273260905","volume":"326","author":"R Adams","year":"1992","unstructured":"Adams R, Nichols F, Carl E et al (1992) The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 326:605\u2013610. https:\/\/doi.org\/10.1056\/NEJM199202273260905","journal-title":"N Engl J Med"},{"key":"2398_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/jcbfm.2009.6","volume":"29","author":"I Prohovnik","year":"2009","unstructured":"Prohovnik I, Hurlet-Jensen A, Adams R et al (2009) Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J Cereb Blood Flow Metab 29:803\u2013810. https:\/\/doi.org\/10.1038\/jcbfm.2009.6","journal-title":"J Cereb Blood Flow Metab"},{"key":"2398_CR27","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1212\/WNL.0000000000005194","volume":"90","author":"ME Fields","year":"2018","unstructured":"Fields ME, Guilliams KP, Ragan DK et al (2018) Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease. Neurology 90:e1134\u2013e1144. https:\/\/doi.org\/10.1212\/WNL.0000000000005194","journal-title":"Neurology"},{"key":"2398_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25727","author":"L V\u00e1clav\u016f","year":"2020","unstructured":"V\u00e1clav\u016f L, Petr J, Petersen ET et al (2020) Cerebral oxygen metabolism in adults with sickle cell disease. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.25727","journal-title":"Am J Hematol"},{"key":"2398_CR29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1182\/blood-2014-06-582403","volume":"124","author":"ML Hulbert","year":"2014","unstructured":"Hulbert ML, Ford AL (2014) Understanding sickle cell brain drain. Blood 124:830\u2013831. https:\/\/doi.org\/10.1182\/blood-2014-06-582403","journal-title":"Blood"},{"key":"2398_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1055\/s-0031-1273087","volume":"37","author":"L De Franceschi","year":"2011","unstructured":"De Franceschi L, Cappellini MD, Olivieri O (2011) Thrombosis and sickle cell disease. Semin Thromb Hemost 37:226\u2013236. https:\/\/doi.org\/10.1055\/s-0031-1273087","journal-title":"Semin Thromb Hemost"},{"key":"2398_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1474-4422(06)70469-0","volume":"5","author":"JA Switzer","year":"2006","unstructured":"Switzer JA, Hess DC, Nichols FT, Adams RJ (2006) Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 5:501\u2013512. https:\/\/doi.org\/10.1016\/S1474-4422(06)70469-0","journal-title":"Lancet Neurol"},{"key":"2398_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11239-016-1418-4","volume":"43","author":"A Al-Awadhi","year":"2017","unstructured":"Al-Awadhi A, Adekile A, Marouf R (2017) Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait. J Thromb Thrombolysis 43:117\u2013123. https:\/\/doi.org\/10.1007\/s11239-016-1418-4","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"2398_CR33","doi-asserted-by":"publisher","first-page":"e014143","DOI":"10.1161\/jaha.119.014143","volume":"9","author":"MT Ito","year":"2020","unstructured":"Ito MT, da Silva Costa SM, Baptista LC et al (2020) Angiogenesis-related genes in endothelial progenitor cells may be involved in sickle cell stroke. J Am Heart Assoc 9(3):e014143. https:\/\/doi.org\/10.1161\/jaha.119.014143","journal-title":"J Am Heart Assoc"},{"key":"2398_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/STROKEAHA.118.020482","volume":"50","author":"KP Guilliams","year":"2019","unstructured":"Guilliams KP, Fields ME, Dowling MM (2019) Advances in understanding ischemic stroke physiology and the impact of vasculopathy in children with sickle cell disease. Stroke 50:266\u2013273. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020482","journal-title":"Stroke"},{"key":"2398_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/bjh.14391","volume":"176","author":"MM Dowling","year":"2017","unstructured":"Dowling MM, Quinn CT, Ramaciotti C et al (2017) Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. Br J Haematol 176:300\u2013308. https:\/\/doi.org\/10.1111\/bjh.14391","journal-title":"Br J Haematol"},{"issue":"3","key":"2398_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11910-016-0622-0","volume":"6","author":"C Lawrence","year":"2016","unstructured":"Lawrence C, Webb J (2016) Sickle cell disease and stroke: diagnosis and management. Curr Neurol Neurosci Rep 6(3):27. https:\/\/doi.org\/10.1007\/s11910-016-0622-0","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"2398_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jpeds.2011.02.009","volume":"159","author":"PC Hines","year":"2011","unstructured":"Hines PC, McKnight TP, Seto W, Kwiatkowski JL (2011) Central nervous system events in children with sickle cell disease presenting acutely with headache. J Pediatr 159(3):472\u2013478. https:\/\/doi.org\/10.1016\/j.jpeds.2011.02.009","journal-title":"J Pediatr"},{"issue":"6","key":"2398_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1468-2982.2006.01092.x","volume":"26","author":"GS Silva","year":"2006","unstructured":"Silva GS, Vicari P, Figueiredo MS, Junior HC, Idagawa MH, Massaro AR (2006) Migraine-mimicking headache and sickle cell disease: a transcranial Doppler study. Cephalalgia 26(6):678\u2013683. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01092.x","journal-title":"Cephalalgia"},{"issue":"3","key":"2398_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jmri.1880080304","volume":"8","author":"RG Steen","year":"1998","unstructured":"Steen RG, Reddick WE, Mulhern RK et al (1998) Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging 8(3):535\u2013543. https:\/\/doi.org\/10.1002\/jmri.1880080304","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2398_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/088307380001500511","volume":"15","author":"RJ Adams","year":"2000","unstructured":"Adams RJ (2000) Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. J Child Neurol 15(5):344\u2013349","journal-title":"J Child Neurol"},{"key":"2398_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","volume":"387","author":"RE Ware","year":"2016","unstructured":"Ware RE, Davis BR, Schultz WH et al (2016) Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, noninferiority trial. Lancet 387:661\u2013670","journal-title":"Lancet"},{"issue":"3","key":"2398_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, K\u00f5rvJ Lal A, Putaala J, Werring DJ (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a European Stroke Organisation guideline. Eur Stroke J 4(3):198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187","journal-title":"Eur Stroke J"},{"key":"2398_CR43","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J et al (2017) Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med 376:429\u2013439","journal-title":"N Engl J Med"},{"issue":"12","key":"2398_CR44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10554-018-1406-1","volume":"34","author":"C Aggeli","year":"2018","unstructured":"Aggeli C, Verveniotis A, Andrikopoulou E et al (2018) Echocardiographic features of PFOs and paradoxical embolism: a complicated puzzle. Int J Cardiovasc Imaging 34(12):1849\u20131861. https:\/\/doi.org\/10.1007\/s10554-018-1406-1","journal-title":"Int J Cardiovasc Imaging"},{"issue":"38","key":"2398_CR45","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehy649","volume":"40","author":"C Pristipino","year":"2019","unstructured":"Pristipino C, Sievert H, D\u2019Ascenzo F et al (2019) European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J 40(38):3182\u20133195. https:\/\/doi.org\/10.1093\/eurheartj\/ehy649","journal-title":"Eur Heart J"},{"issue":"4","key":"2398_CR46","doi-asserted-by":"publisher","first-page":"e14276","DOI":"10.1097\/md.0000000000014276","volume":"98","author":"H Zhao","year":"2019","unstructured":"Zhao H, Yue Q, Wang T, Wang L, Pang Z, Dong H, Yang J, Li Y, Li S (2019) Sensitivity of contrast-enhanced transthoracic echocardiography for the detection of residual shunts after percutaneous patent foramen ovale closure. Medicine 98(4):e14276. https:\/\/doi.org\/10.1097\/md.0000000000014276","journal-title":"Medicine"},{"issue":"2","key":"2398_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.echo.2019.09.018","volume":"33","author":"Y Takaya","year":"2020","unstructured":"Takaya Y, Watanabe N, Ikeda M et al (2020) Importance of abdominal compression Valsalva maneuver and microbubble grading in contrast transthoracic echocardiography for detecting patent foramen ovale. J Am Soc Echocardiogr 33(2):201\u2013206. https:\/\/doi.org\/10.1016\/j.echo.2019.09.018","journal-title":"J Am Soc Echocardiogr"},{"issue":"8\u20139","key":"2398_CR48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.acvd.2019.06.002","volume":"112","author":"JL Mas","year":"2019","unstructured":"Mas JL, Derex L, Gu\u00e9rin P et al (2019) Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: expert consensus of the French Neurovascular Society and the French Society of Cardiology. Arch Cardiovasc Dis 112(8\u20139):532\u2013542. https:\/\/doi.org\/10.1016\/j.acvd.2019.06.002","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"2398_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jpeds.2009.10.012","volume":"156","author":"MM Dowling","year":"2010","unstructured":"Dowling MM, Lee N, Quinn CT et al (2010) Prevalence of intracardiac shunting in children with sickle cell disease and stroke. J Pediatr 156(4):645\u2013650. https:\/\/doi.org\/10.1016\/j.jpeds.2009.10.012","journal-title":"J Pediatr"},{"key":"2398_CR50","doi-asserted-by":"publisher","first-page":"516705","DOI":"10.1155\/2013\/516705","volume":"2013","author":"S Razdan","year":"2013","unstructured":"Razdan S, Strouse JJ, Naik R et al (2013) Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case Rep Hematol 2013:516705. https:\/\/doi.org\/10.1155\/2013\/516705","journal-title":"Case Rep Hematol"},{"issue":"1","key":"2398_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.15420\/icr.2018.33.2","volume":"14","author":"JP Giblett","year":"2019","unstructured":"Giblett JP, Abdul-Samad O, Shapiro LM, Rana BS, Calvert PA (2019) Patent foramen ovale closure in 2019. Interv Cardiol Rev 14(1):34\u201341. https:\/\/doi.org\/10.15420\/icr.2018.33.2","journal-title":"Interv Cardiol Rev"},{"key":"2398_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.120.030335","author":"S Yaghi","year":"2020","unstructured":"Yaghi S, Ishida K, Torres J et al (2020) SARS2-CoV-2 and stroke in a new york healthcare system. Stroke. https:\/\/doi.org\/10.1161\/strokeaha.120.030335","journal-title":"Stroke"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02398-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:44:50Z","timestamp":1744170290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02398-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"9 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}